Priority from the Idiopathic Intracranial Hypertension PSP

UNCERTAINTY: Do the benefits of the drug treatments for IIH outweigh the side effects?
Overall ranking This was one of the 16 questions at the workshop that fell outside of the Top 10.
JLA question ID 0066/14
Explanatory note Not available for this PSP
Evidence

None identified
Health Research Classification System category Neurological
Extra information provided by this PSP
Original uncertainty examples Should all individuals be counselled regarding weight loss despite their starting BMI? ~ What is the safety (in terms of medication overuse outcomes), efficacy and optimum dose of acetozolamide for chronic treatment of raised intracranial pressure in people with IIH? ~ What is the maximum therapeutic dose of acetazolemide that should be given to treat vision problems in people with IIH?
Submitted by See data spreadsheet on JLA website
PSP information
PSP unique ID 0066
PSP name Idiopathic Intracranial Hypertension
Total number of uncertainties identified by this PSP. 48  (To see a full list of all uncertainties identified, please see the detailed spreadsheet held on the JLA website)
Date of priority setting workshop 27 April 2018